How much revenue did Inventiva generate this year?
Inventiva has achieved a revenue of 2.59 M EUR this year.
Inventiva Revenue 2024
Inventiva Revenue
2.59 M EUR
Ticker
IVA.PA
ISIN
FR0013233012
WKN
A2DLV9
In 2024, Inventiva's sales reached 2.59 M EUR, a -85.16% difference from the 17.48 M EUR sales recorded in the previous year.
The Inventiva Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 428.36 | 4,16 |
| 2028e | 248.49 | 7,17 |
| 2027e | 68.88 | 25,86 |
| 2026e | 35.44 | 50,27 |
| 2025e | 14.78 | 120,52 |
| 2024e | 2.59 | 686,78 |
| 2023 | 17.48 | 101,93 |
| 2022 | 12.18 | 146,28 |
| 2021 | 4.19 | 178,35 |
| 2020 | 0.37 | 1186,56 |
| 2019 | 7 | 254,57 |
| 2018 | 3.2 | 557,24 |
| 2017 | 4.8 | 371,38 |
| 2016 | 9.45 | 188,61 |
| 2015 | 4.88 | 365,44 |
| 2014 | 3.28 | 542,64 |
| 2013 | 3.07 | 580,29 |
Inventiva Revenue, EBIT, Net Income FR0013233012 · A2DLV9
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Inventiva, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Inventiva from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Inventiva’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Inventiva. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Inventiva’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Inventiva’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Inventiva’s growth potential.
Inventiva Revenue, EBIT and net profit per share
| Date | Inventiva Revenue | Inventiva EBIT | Inventiva Net Income |
|---|---|---|---|
| 2029e | 428.36 M undefined | 0 undefined | 6.94 M undefined |
| 2028e | 248.49 M undefined | 37.87 M undefined | -11.21 M undefined |
| 2027e | 68.88 M undefined | -84.78 M undefined | -49.66 M undefined |
| 2026e | 35.44 M undefined | -113.08 M undefined | -88.65 M undefined |
| 2025e | 14.78 M undefined | -123.7 M undefined | -99.45 M undefined |
| 2024e | 2.59 M undefined | -131.23 M undefined | -121.53 M undefined |
| 2023 | 17.48 M undefined | -102.67 M undefined | -110.43 M undefined |
| 2022 | 12.18 M undefined | -56.86 M undefined | -54.27 M undefined |
| 2021 | 4.19 M undefined | -51.16 M undefined | -49.64 M undefined |
| 2020 | 372,000 undefined | -29.7 M undefined | -33.62 M undefined |
| 2019 | 7 M undefined | -30.31 M undefined | -30.22 M undefined |
| 2018 | 3.2 M undefined | -29.86 M undefined | -33.62 M undefined |
| 2017 | 4.8 M undefined | -22.19 M undefined | -19.08 M undefined |
| 2016 | 9.45 M undefined | -12.05 M undefined | -7.05 M undefined |
| 2015 | 4.88 M undefined | -14.88 M undefined | -8.82 M undefined |
| 2014 | 3.28 M undefined | -13.47 M undefined | -7.49 M undefined |
| 2013 | 3.07 M undefined | -12.47 M undefined | -7.14 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2013 | 3.07 M EUR | -12.47 M EUR | -7.14 M EUR |
| 2014 | 3.28 M EUR | -13.47 M EUR | -7.49 M EUR |
| 2015 | 4.88 M EUR | -14.88 M EUR | -8.82 M EUR |
| 2016 | 9.45 M EUR | -12.05 M EUR | -7.05 M EUR |
| 2017 | 4.8 M EUR | -22.19 M EUR | -19.08 M EUR |
| 2018 | 3.2 M EUR | -29.86 M EUR | -33.62 M EUR |
| 2019 | 7 M EUR | -30.31 M EUR | -30.22 M EUR |
| 2020 | 372,000 EUR | -29.7 M EUR | -33.62 M EUR |
| 2021 | 4.19 M EUR | -51.16 M EUR | -49.64 M EUR |
| 2022 | 12.18 M EUR | -56.86 M EUR | -54.27 M EUR |
| 2023 | 17.48 M EUR | -102.67 M EUR | -110.43 M EUR |
| 2024e | 2.59 M EUR | -131.23 M EUR | -121.53 M EUR |
| 2025e | 14.78 M EUR | -123.7 M EUR | -99.45 M EUR |
| 2026e | 35.44 M EUR | -113.08 M EUR | -88.65 M EUR |
| 2027e | 68.88 M EUR | -84.78 M EUR | -49.66 M EUR |
| 2028e | 248.49 M EUR | 37.87 M EUR | -11.21 M EUR |
| 2029e | 428.36 M EUR | 0 EUR | 6.94 M EUR |
Inventiva stock margins FR0013233012 · A2DLV9
The Inventiva margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inventiva. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inventiva.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Inventiva's sales revenue. A higher gross margin percentage indicates that the Inventiva retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Inventiva's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Inventiva's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Inventiva's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Inventiva. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Inventiva's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Inventiva Margin History
| Inventiva Gross margin | Inventiva Profit margin | Inventiva EBIT margin | Inventiva Profit margin |
|---|---|---|---|
| 2029e | 146.28 % | 0 % | 1.62 % |
| 2028e | 146.28 % | 15.24 % | -4.51 % |
| 2027e | 146.28 % | -123.09 % | -72.1 % |
| 2026e | 146.28 % | -319.07 % | -250.13 % |
| 2025e | 146.28 % | -836.82 % | -672.79 % |
| 2024e | 146.28 % | -5,059.09 % | -4,684.96 % |
| 2023 | 146.28 % | -587.43 % | -631.84 % |
| 2022 | 146.28 % | -466.84 % | -445.64 % |
| 2021 | 178.35 % | -1,219.89 % | -1,183.48 % |
| 2020 | 1,186.56 % | -7,983.87 % | -9,037.37 % |
| 2019 | 146.28 % | -433.15 % | -431.81 % |
| 2018 | 146.28 % | -933.94 % | -1,051.52 % |
| 2017 | 146.28 % | -462.58 % | -397.81 % |
| 2016 | 146.28 % | -127.56 % | -74.59 % |
| 2015 | 146.28 % | -305.13 % | -180.98 % |
| 2014 | 146.28 % | -410.2 % | -228.27 % |
| 2013 | 146.28 % | -406.19 % | -232.57 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2013 | 146.28 % | -406.19 % | -232.57 % |
| 2014 | 146.28 % | -410.2 % | -228.27 % |
| 2015 | 146.28 % | -305.13 % | -180.98 % |
| 2016 | 146.28 % | -127.56 % | -74.59 % |
| 2017 | 146.28 % | -462.58 % | -397.81 % |
| 2018 | 146.28 % | -933.94 % | -1,051.52 % |
| 2019 | 146.28 % | -433.15 % | -431.81 % |
| 2020 | 1,186.56 % | -7,983.87 % | -9,037.37 % |
| 2021 | 178.35 % | -1,219.89 % | -1,183.48 % |
| 2022 | 146.28 % | -466.84 % | -445.64 % |
| 2023 | 146.28 % | -587.43 % | -631.84 % |
| 2024e | 146.28 % | -5,059.09 % | -4,684.96 % |
| 2025e | 146.28 % | -836.82 % | -672.79 % |
| 2026e | 146.28 % | -319.07 % | -250.13 % |
| 2027e | 146.28 % | -123.09 % | -72.1 % |
| 2028e | 146.28 % | 15.24 % | -4.51 % |
| 2029e | 146.28 % | 0 % | 1.62 % |
Inventiva Aktienanalyse
What does Inventiva do?
Inventiva SA is a biopharmaceutical company based in France that specializes in the development of novel therapies for various diseases. The company was founded in 2002 by Pierre Broqua and Frédéric Cren to develop innovative drugs based on research on the human genome. Inventiva's business model is to develop a pipeline of drug candidates and either sell them or bring them into partnerships with other companies. The company has built a broad portfolio of patents and license agreements that allow it to develop a variety of products. Inventiva's research and development focuses on three key areas: fibrosis, oncology, and autoimmune diseases. In these areas, the company has several product candidates in various stages of clinical development. Inventiva's products include Lanifibranor, a drug for the treatment of fatty liver disease, which is currently in Phase III trials. Additionally, the company has several compounds in its oncology pipeline, including IVA337, IVA336, and IVA339, all of which have shown promising results in preclinical studies. In the field of autoimmune diseases, Inventiva is working on a compound called ABBV-157, which is being developed in collaboration with Abbvie. This compound is intended to help reduce inflammation in patients with rheumatoid arthritis and psoriasis. Overall, Inventiva has made significant progress in recent years and has achieved important milestones in the development of its products. The company has also entered into several partnerships with major pharmaceutical and biotech companies to bring its products to market. In 2020, Inventiva took the next important step in its growth strategy by announcing a merger with American company AbbVie. The acquisition is expected to accelerate the development and commercialization of Inventiva's products and provide the company with a strong partner in the international market. However, Inventiva has not limited itself to drug development. The company has also developed a range of services to support other companies in the development of new drugs. These include laboratory services, protein purification and analysis, cell culture, and more, offered through their own contract research organization (CRO) unit. In summary, Inventiva is an emerging company with a strong portfolio of products and services. The company has done excellent work in developing new medical technologies in recent years and is likely to have even more success in the future with the acquisition by AbbVie. Inventiva ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Inventiva's Sales Figures
The sales figures of Inventiva originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Inventiva’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Inventiva's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Inventiva’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Inventiva stock
How much was the turnover of the company Inventiva compared to the previous year?
The revenue of Inventiva has increased by -85.16% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Inventiva?
The revenue of Inventiva is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Inventiva measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Inventiva so important for investors?
The revenue of Inventiva is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Inventiva pay?
Over the past 12 months, Inventiva paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inventiva is expected to pay a dividend of 0 EUR.
What is the dividend yield of Inventiva?
The current dividend yield of Inventiva is .
When does Inventiva pay dividends?
Inventiva pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Inventiva?
Inventiva paid dividends every year for the past 0 years.
What is the dividend of Inventiva?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Inventiva located?
Inventiva is assigned to the 'Health' sector.
Wann musste ich die Aktien von Inventiva kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Inventiva from 9/26/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.
When did Inventiva pay the last dividend?
The last dividend was paid out on 9/26/2024.
What was the dividend of Inventiva in the year 2023?
In the year 2023, Inventiva distributed 0 EUR as dividends.
In which currency does Inventiva pay out the dividend?
The dividends of Inventiva are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Inventiva
Our stock analysis for Inventiva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inventiva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
